Charles Schwab Investment Management Inc Pliant Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 251,365 shares of PLRX stock, worth $462,511. This represents 0.0% of its overall portfolio holdings.

Number of Shares

251,365

Previous 389,349 35.44%

Holding current value

$462,511

Previous $525,000 44.57%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$1.16 - $1.69 $160,061 - $233,192	-137,984 Reduced 35.44%	251,365 $291,000
Q1 2025 Sep 15, 2025	BUY	$1.35 - $13.53 $186,278 - $1.87 Million	137,984 Added 54.89%	389,349 $525,000
Q1 2025 May 09, 2025	SELL	$1.35 - $13.53 $94,547 - $947,573	-70,035 Reduced 15.25%	389,349 $525,000
Q4 2024 Feb 06, 2025	BUY	$10.55 - $15.7 $28,706 - $42,719	2,721 Added 0.6%	459,384 $6.05 Million
Q3 2024 Nov 12, 2024	BUY	$10.52 - $14.35 $202,836 - $276,682	19,281 Added 4.41%	456,663 $5.12 Million
Q2 2024 Aug 12, 2024	BUY	$10.58 - $15.61 $75,075 - $110,768	7,096 Added 1.65%	437,382 $4.7 Million
Q1 2024 May 08, 2024	BUY	$14.14 - $19.59 $86,112 - $119,303	6,090 Added 1.44%	430,286 $6.41 Million
Q4 2023 Feb 06, 2024	BUY	$12.85 - $19.15 $76,971 - $114,708	5,990 Added 1.43%	424,196 $7.68 Million
Q3 2023 Nov 08, 2023	BUY	$14.58 - $20.15 $894,862 - $1.24 Million	61,376 Added 17.2%	418,206 $7.25 Million
Q2 2023 Aug 09, 2023	BUY	$18.12 - $30.56 $2.54 Million - $4.29 Million	140,314 Added 64.81%	356,830 $6.47 Million
Q1 2023 May 11, 2023	BUY	$18.73 - $36.26 $821,497 - $1.59 Million	43,860 Added 25.4%	216,516 $5.76 Million
Q4 2022 Feb 13, 2023	BUY	$17.0 - $25.43 $64,226 - $96,074	3,778 Added 2.24%	172,656 $3.34 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $554,817 - $1.75 Million	72,336 Added 74.93%	168,878 $3.53 Million
Q2 2022 Aug 15, 2022	SELL	$4.11 - $8.75 $288,665 - $614,556	-70,235 Reduced 42.11%	96,542 $774,000
Q1 2022 May 13, 2022	BUY	$7.01 - $14.1 $33,570 - $67,524	4,789 Added 2.96%	166,777 $1.17 Million
Q4 2021 Feb 11, 2022	BUY	$12.27 - $18.26 $46,957 - $69,881	3,827 Added 2.42%	161,988 $2.19 Million
Q3 2021 Nov 16, 2021	BUY	$16.48 - $28.98 $1.04 Million - $1.83 Million	63,282 Added 66.7%	158,161 $2.67 Million
Q2 2021 Aug 16, 2021	BUY	$28.05 - $37.69 $38,091 - $51,183	1,358 Added 1.45%	94,879 $2.76 Million
Q1 2021 May 17, 2021	BUY	$24.52 - $40.23 $725,203 - $1.19 Million	29,576 Added 46.25%	93,521 $3.68 Million
Q4 2020 Feb 16, 2021	BUY	$19.89 - $32.99 $18,557 - $30,779	933 Added 1.48%	63,945 $1.45 Million
Q3 2020 Nov 13, 2020	BUY	$21.54 - $29.53 $1.36 Million - $1.86 Million	63,012 New	63,012 $1.43 Million

Others Institutions Holding PLRX

# of Institutions

125

Shares Held

57.7M

Call Options Held

245K

Put Options Held

86.7K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $89.6M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Pliant Therapeutics, Inc. Transaction History